Induction of DM by STZ injection in rats
T1DM in 24 female Sprague–Dawley healthy rats was induced by subcutaneously injecting STZ (50 mg/kg in Citrate buffer). The same inclusion and exclusion criteria described earlier in this study were applied. On the other side, 6 normal non-diabetic rats were selected to be as a control group. FBG and body weight were measured after 72 h of STZ induction. 10 days after induction of diabetes; 18 STZ rats were randomized using simple randomization method into the 3 groups; and then they were categorized into three groups; STZ + PBS group (6 non-treated STZ-induced diabetic rats), STZ + DM-Ad-MSCs group (6 STZ-induced diabetic rats treated with DM-Ad-MSCs in PBS), STZ + Normal-Ad-MSCs group: (6 STZ-induced diabetic rats treated with N-Ad-MSCs in PBS).The animals groups were blindly checked for FBG and BWs by an independent technician.
Transplantation of Ad-MSCs
On the day of injection, each fasted rat from STZ + DM-MSCs and STZ + Normal–MSCs group received 1–1.5 × 106 freshly trypsinized P3-P4 (DM-Ad-MSCs) and (N-Ad-MSCs), respectively, where cells were suspended in 1 mL PBS. Cells suspended in PBS were transplanted into tail veins using a 1 mL 100-unit 27-gauge insulin syringe. FBG and BW were measured every 7 days after the day of transplantation for 35 days only. Transplantation was done by the same experimenter for all animals and blindly regarding the groups.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.